Polypharmacy in the Elderly from the Clinical Toxicologist Perspective;Polypharmazie beim älteren Patienten aus Sicht des klinischen Toxikologen

Zeitschrift fur Gerontologie und Geriatrie

Volumn 45, Issue 6, 2012, Pages 473-478

  Heppner, H J ^a,b   Christ, M ^a   Gosch, M ^c   Muhlberg W ^b,d   Bahrmann, P ^a,b   Bertsch, T ^a   Sieber, C ^a,b   Singler, K ^a,b  

^a KLINIKUM NÜRNBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c LKH Hochzirl ^*  (Austria)

^d SANOFI   (France)

Author keywords

Clinical toxicology; Elderly; Poison control centers; Poisoning; Polypharmacy

Indexed keywords

AGED; ARTICLE; DRUG INTERACTION; DRUG TOXICITY; FEMALE; GERMANY; HUMAN; INCIDENCE; INTOXICATION; MALE; MORTALITY; POLYPHARMACY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; DRUG INTERACTIONS; DRUG TOXICITY; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; POISONING; POLYPHARMACY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84865743193     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-012-0383-6     Document Type: Article

References (54)

1. Afilalo J, Karunananthan S, Eisenberg M et al (2009) Role of frailty in patients with cardiovascular disease. Am J Cardiol 103:1616-1621
2. Antoniou T, Gomes T, Mamdami MM et al (2011) Trimethoprom-sulfamethoxazole induced hyperkalaemian in elderly patients reciving spironolactone: nested case-control study. BMJ 343:d5228
3. Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 157:1531-1536
4. Bennet AT, Collins KA (2001) Elderly suicide: a 10-year retrospective study. Am J Forensic Med Pathol 22:169-172
5. Betteridge TM, Frampton CM, Jardine DL (2012) Polypharmacy-we make it worse! A cross-sectional study from an acute admission unit. Intern Med J 42:208-211
6. Boyle N, Naganathan V, Cumming RG (2010) Medication and falls: risk and optimization. Clin Geriatr Med 26:583-605
7. Budnitz DS, Lovegrove MC, Shehab N et al (2011) Emergency hospitalizations for adverse drug events in older americans. N Engl J Med 365:2002-2012
8. Cahir C, Fahey T, Teeling M et al (2010) Potentially inappropriate prescribing and cost outcome of older people: a national population study. Br J Clin Pharmacol 69:543-552
9. Cassidy N, Lee SK, Donegan CF, Tracey JA (2008) Poisoning in older adults: the experience of the national poisons information centre. Ir Med J 101:268-270
10. Ciorciaro C, Hartmann K, Kuhn M (1998) Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ. Schweiz Med Wochenschr 128:254-258
11. Comets E, Diquet B, Legrain S et al (2012) Pharmacokinetic and pharmacodynamic varaibility of fluindione in Octogenarians. Clin Pharmacol Ther 4:777-787
12. Cook R, Allcock R, Johnston M (2008) Self-poisoning: current trends and practice in a UK teaching hospital. Clin Med 8:37-40
13. Dendorfer U, Mann J (2006) Drug related disorders of water and electrolyte metabolism. Internist 47:1121-1128
14. Doak MW, Nixon AC, Lupton DJ et al (2009) Self-poisoning in older adults: patterns of drug ingestion and clinical outcomes. Age Ageing 38:407-411
15. Dormann H, Neubert A, Criegee-Rieck M et al (2004) Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 255(6):653-663
16. Dovjak P, Sommeregger U, Otto R et al (2010) Polypharmazie in der Kardiologie - ein beachtliches Problem bei Synkopen, QT-Zeit-Verlängerung, Bradykardie und Tachykardie. Wien Med Wochenschr 160:264-269
17. Dragonas C, Wagner JT, Heppner HJ et al (2007) The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients. Eur J Clin Pharmacol 16:367-372
18. Egger T, Dormann H, Ahne G et al (2003) Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 20:769-776
19. Fick DM, Cooper JW, Wade WE et al (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716-2724
20. Finlayson E, Maselli J, Steinmann MA et al (2011) Inappropriate medication use in older adults undergoing surgery: a national study. J Am Geriatr Soc 59:139-144
21. Gandhi TK, Weingart SN, Borus J et al (2003) Adverse drug events in ambulatory care. N Engl J Med 348:1556
22. Gillespie U, Alassaad A, Henrohn D et al (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch Intern Med 169:894-900
23. Gosch M, Roller R (2010) Multiple drug therapy: a challange for an aging society. Wien Med Wochenschr 160:261-263
24. Hadem J, Tacke F, Bruns T et al (2012) Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol 10:664-669
25. Hartikainen S, Lönnroos E, Louhivuori K (2007) Medication as a risk factor for falls: critical systematic review. J Gerontol Med Sci 62A:1172-1181
26. Heyerdahl F, Bjornas MA, Hovda KE et al (2008) Acute poisonings treated in hospitals in Oslo. A one-year prospective study (II): clinical outcome. Clin Toxicol 46:2-9
27. Hicks LA, Chien YW, Taylor TH et al (2011) Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 53:631-639
28. Holt S, Schmiedl S, Thürmann PA (2010) Potenziell inadäquate Medikation für ältere Menschen: Die PRISCUS-Liste. Dtsch Arztebl Int 107:543-551
29. http://www.who.int/ipcs/poisons/harmonization/en/index.html. Accessed 17 May 2012
30. Huang AR, Mallet L, Rochfort CM et al (2012) Medicatiion-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 29:359-376
31. Juurlink DN, Mamdami MM, Lee DS et al (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 351:543-551
32. Juurlink DN, Mamdani M, Koop A et al (2003) Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289:1652-1658
33. Kämmerer W, Mutschler E (1998) Arzneistoffwechselwirkungen in der Intensivmedizin. Rhein Main Druck, Mainz, Germany
34. Kämmerer W (2012) Klinisch relevante pharmakokinetische Arzneimittelinteraktionen in der Intensivmedizin. Med Klin Intensivmed Notfmed 107:128-140
35. Krämer I, Rauber-Lüthy C, Kupferschmidt H, Krähenbühl S et al (2010) Minimal dose for severe poisoning and influencing factors in acute human clozapine intoxication: a 13-year retrospective study. Clin Neuropharmacol 33:230-234
36. Lau HS, Florax C, Porsius AJ et al (2000) The completness of medication histories in medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 49:597-603
37. Mizukami F, Koide Y, Furuta K (2012) Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother 10:123-128
38. Modreker MK, Rentelen-Kruse W von (2009) Arzneimittel und Stürze im Alter. Internist 50:493-500
39. Mühlberg W, Becher K, Heppner HJ, Wicklein S et al (2005) Acute poisoning in old and very old patients: a longitudinal retrospective study of 5883 patients in a toxicological intensive care unit. Z Gerontol Geriat 38:182-189
40. Onder G, Liperoti R, Fidlova D et al (2012) Polypharamcy in nursing homes in Europe: the results from the SHELTER study. J Gerontol A Biol Sci Med Sci 67A:698-704
41. Pomme E, Ficek B (2012) Management of pain in the elderly at the end of life. Drug and Aging 29:285-305
42. Punywudho B, Ramsay ER, Brundage RC et al (2012) Population pharmacokinetics of carbamazepine in elderly patients. Ther Drug Monit 34:176-81
43. Rammer M, Weber T, Laßing M et al (2009) Arterial Hypertension and electrolyte disturbances. J Hyperton 13:12-16
44. Rogers JJ, Heard K (2007) Does age matter? Comparing case fatality rates for selected poisonings reported to U.S. poison centers. Clinical Toxicology 45:705-708
45. Ruiter R, Visser LE, Rodenburg EM et al (2012) Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in The Netherlands. Drugs Aging 29:225-232
46. Saad M, Harisingani R, Katinas L (2012) Impact of geriatric consultation on the number of medications in hospitalized older patients. Consult Pharm 27:42-48
47. Satar S, Seydaoglu G (2005) Analysis of acute adult poisoning in a 6-year period and factors affecting the hospital stay. Adv Ther 22:137-147
48. Schnurrer J, Frölich JC (2003) Incidence and prevention of lethal undisirable drug effects. Internist 44:889
49. Slomski A (2012) Falls form taking multiple medications may be a risk for both young and old. JAMA 307:1127-1128
50. Solomon DH, Rassen JA, Glynn RJ et al (2010) The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 170:1968-1978
51. Strandell J, Bate A, Hägg S et al (2009) Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. Br J Clin Pharmacol 68:427-434
52. Tinetti M, Allore H, Arauja K (2007) Modifiable impairments predict progressive disability among older persons. J Aging Health 17:239-256
53. Ventura MT, Laddaga R, Cavallera P et al (2010) Adverse drug reactions as the cause of emergency department admission: focus on the elderly. Immunopharmacol Immunotoxicol 32:426-429
54. Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of nine medication classes on falls in elderly persons. Arch Intern Med 169:1952-1960